Haliangicin, a novel antifungal metabolite produced by a marine myxobacterium. 2. Isolation and structural elucidation

Journal of Antibiotics

Volumn 54, Issue 2, 2001, Pages 153-156

  Fudou, R ^a   Iizuka, T ^a   Sato, S ^a   Ando, T ^a   Shimba, N ^a   Yamanaka, S ^a  

^a AJINOMOTO CO INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID ETHYL ESTER; ACRYLIC ACID DERIVATIVE; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CARBONYL DERIVATIVE; ESTER DERIVATIVE; HALIANGICIN; METHANOL; NEW DRUG; RESIN; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; AQUATIC FAUNA; ARTICLE; BACTERIUM CULTURE; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG ISOLATION; DRUG STRUCTURE; METABOLITE; MYXOCOCCALES; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SPECTROSCOPY; STRUCTURE ANALYSIS;

HALIANGIUM LUTEUM;

EID: 0035079997     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.54.153     Document Type: Article

References (5)

1. Myxobacteria as producers of secondary metabolites
2. Production of bioactive secondary metabolites
3. Isolation of myxobacteria from the marine environment
4. Haliangicin, a novel antifungal metabolites, produced by marine myxobacteria. 1. Fermentation and biological characteristics
5. Natural abundance nitrogen-15 NMR by enhanced heteronuclear spectroscopy